FeesSafety
Pluang+

$39.2M Fannie Mae loan funds sale of 334-unit multifamily property in Mansfield, Texas.

Company Fundamentals
10 Nov 2026, 18:24 WIB
GlobeNewsWire
View Source
Bullish
$39.2M Fannie Mae loan funds sale of 334-unit multifamily property in Mansfield, Texas.

Cushman & Wakefield and Greystone facilitated the sale and arranged $39.2 million in Fannie Mae financing for Evolv, a 334-unit multifamily property in Mansfield, Texas. The fixed-rate loan has a five-year term with interest-only payments for three years, supporting Greybrook Realty Partners' acquisition. Evolv, built in 2012, offers modern amenities and is part of Greybrook's U.S. Multifamily Income & Growth Fund, expanding their portfolio in growing U.S. markets. This deal highlights strong investor interest in the Dallas-Fort Worth area and provides Greybrook with long-term capital for future growth.

The $39.2 million Fannie Mae financing for a multifamily property in Mansfield, Texas, provides context for readers. For those following the Real Estate sector, here is Pluang's market snapshot as of Nov 10, 2026 22:31 WIB: out of 47 priced US Real Estate stocks, 5 rose and 42 fell. Notable movers include BEKE at USD 18.05 with a -1.90% change, JLL at USD 373.05 with a -1.85% change, and IIPR at USD 54.52 with a -1.85% change and a typical hold time of 89 days, with Pluang order activity showing 51% Sell and 49% Buy.

More News

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...

Company Fundamentals
Neutral
1 hour ago
EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...

Company Fundamentals
Neutral
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
2 hours ago
Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
2 hours ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App